Nature
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
Gene-editing strategies that allow stem cells to evade the immune system offer hope for universal cell-replacement therapies.
Imaging and molecular manipulation reveal how ‘condensates’ form and offer clues to the role of phase separation in health and disease.
Researchers are blasting patients’ cancer cells with dozens of drugs in the hope of finding the right treatment.
Rogue antibodies are drawn to the protein–RNA coating on half of the X chromosomes in an XX cell.
How a biochemist finally gained recognition for her part in developing multibillion-dollar weight-loss drugs.
Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making.
The commercial success of RNA vaccines for COVID-19 has revved up interest in circular RNAs as the next generation of therapies.
Nature talks to experts about how mRNA is transforming medicine.
Software from Baidu Research yields jabs for COVID that have greater shelf stability and that trigger a larger antibody response in mice than conventionally designed shots.